Sanofi: Annual General Shareholder Meeting of May 4, 2016
(Thomson Reuters ONE) -
Annual General Shareholder Meeting of May 4, 2016
* Shareholder approval of the financial statements for 2015
* Dividend of ?2.93 per share payable as of May 12, 2016
* Board Composition: appointments and reappointments
Paris, France - May 4, 2016 - The Combined General Shareholder Meeting of Sanofi
was held today at the Palais des Congrès in Paris under the chairmanship of
Serge Weinberg. All resolutions submitted to the vote were adopted by its
shareholders.
The shareholders approved, among other resolutions, the individual Company and
consolidated financial statements for the year 2015. At the General Meeting,
shareholders decided the distribution of a cash dividend in the amount of ?
2.93 per share with payment as of May 12, 2016.
The General Meeting also approved the appointment of Diane Souza and Thomas
Südhof as independent Directors and renewed as Directors Laurent Attal, Claudie
Haigneré and Carole Piwnica, for a term of four years, i.e., until the General
Meeting called to approve the financial statements for the year 2019.
Following the General Meeting, the new Board of Directors is comprised of 13
members, of whom six are women. A large majority of the Board's Directors is
independent
* Serge Weinberg,* Chairman of the Board of Directors
* Olivier Brandicourt, Chief Executive Officer
* Laurent Attal
* Bonnie Bassler *
* Robert Castaigne *
* Claudie Haigneré *
* Patrick Kron*
* Fabienne Lecorvaisier *
* Suet-Fern Lee *
* Christian Mulliez
* Carole Piwnica *
* Diane Souza*
* Thomas Südhof*
The voting results will be available on the Company's website (www.sanofi.com)
in the coming days.
The audiocast of the Annual General Shareholder Meeting is available on the
Company's website (www.sanofi.com).
During the Board of Directors session following the meeting, the Board decided
to appoint Diane Souza as a member of the Compensation Committee.
(* Independent Director)
About Sanofi
Sanofi, a global healthcare leader, discovers, develops and distributes
therapeutic solutions focused on patients' needs. Sanofi is organized into five
global business units: Diabetes and Cardiovascular, General Medicines and
Emerging Markets, Sanofi Genzyme, Sanofi Pasteur and Merial. Sanofi is listed in
Paris (EURONEXT: SAN) and in New York (NYSE: SNY).
--------------------------------------------------------------------------------
Contacts:
Media Relations Investors Relations
Laurence Bollack Sébastien Martel
+ (33) 1 53 77 46 46 + (33) 1 53 77 45 45
mr(at)sanofi.com ir(at)sanofi.com
Annual General Shareholder Meeting of May 4, 2016:
http://hugin.info/152918/R/2009817/743891.pdf
This announcement is distributed by GlobeNewswire on behalf of
GlobeNewswire clients. The owner of this announcement warrants that:
(i) the releases contained herein are protected by copyright and
other applicable laws; and
(ii) they are solely responsible for the content, accuracy and
originality of the information contained therein.
Source: Sanofi via GlobeNewswire
[HUG#2009817]
Unternehmensinformation / Kurzprofil:
Datum: 04.05.2016 - 18:12 Uhr
Sprache: Deutsch
News-ID 468762
Anzahl Zeichen: 3801
contact information:
Town:
PARIS
Kategorie:
Business News
Diese Pressemitteilung wurde bisher 326 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"Sanofi: Annual General Shareholder Meeting of May 4, 2016"
steht unter der journalistisch-redaktionellen Verantwortung von
Sanofi (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
